Hydroquinone: Difference between revisions
Kiran Singh (talk | contribs) No edit summary |
Kiran Singh (talk | contribs) No edit summary |
||
Line 35: | Line 35: | ||
* Children 12 years of age and under; safety not established. | * Children 12 years of age and under; safety not established. | ||
|postmarketing=Dermatologic: Burning sensation, [[contact dermatitis]], localized [[erythema]] | |postmarketing=Dermatologic: Burning sensation, [[contact dermatitis]], localized [[erythema]] | ||
|othersTitle=Others | |othersTitle=Others | ||
|administration='''Topical''' | |administration='''Topical''' | ||
Line 59: | Line 50: | ||
}} | }} | ||
{{LabelImage | {{LabelImage | ||
|fileName= | |fileName=Hydroquinone ingredients and appearance.png | ||
}} | }} | ||
{{LabelImage | {{LabelImage | ||
|fileName=Active 4.jpg | |fileName=Active 4.jpg | ||
}} | }} |
Revision as of 17:46, 22 December 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Hydroquinone is a hyperpigmentation agent that is FDA approved for the treatment of discoloration of skin, hyperpigmentation of skin. Common adverse reactions include burning sensation, contact dermatitis, localized erythema.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indications
- Skin Lightening
To gradually lighten hyperpigmentation of the skin such as age spots, liver spots, freckles or hyperpigmentation that can occur as a result of pregnancy or the use of oral contraceptives.
Dosing
- Use fingertips to apply a thin layer to affected areas. Use both morning and night or as directed by a physician. Gradual lightening of the discolored area can be expected in most cases.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
Indications and Dosage
- Discoloration of skin: emulsion, apply TOPICALLY twice daily to affected area(s) or as directed by physician for no longer than 2 months.
- Hyperpigmentation of skin: cream and gel, with or without sunscreens, apply TOPICALLY twice daily to the affected area(s) or as directed by physician for no longer than 2 months; rub in well.
- Hyperpigmentation of skin: cream with sunblock, apply TOPICALLY twice daily to the affected area(s) or as directed by physician for no longer than 2 months; do not rub in.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Hydroquinone in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Hydroquinone FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
Indications and Dosage
- Safety and efficacy not established in children less than 12 years of age; not recommended for use except under physician supervision.
- Discoloration of skin: 12 years and older; emulsion, apply TOPICALLY twice daily to affected area(s) or as directed by physician for no longer than 2 months.
- Hyperpigmentation of skin: 12 years and older; cream and gel, with or without sunscreens, apply TOPICALLY twice daily to the affected area(s) or as directed by physician for no longer than 2 months; rub in well.
- Hyperpigmentation of skin: 12 years and older; cream with sunblock, apply TOPICALLY twice daily to the affected area(s) or as directed by physician for no longer than 2 months; do not rub in.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Hydroquinone in pediatric patients.
Contraindications
- Hypersensitivity to hydroquinone or any component of hydroquinone products.
- Pregnancy, safety not established.
- Children 12 years of age and under; safety not established.
Warnings
There is limited information regarding Hydroquinone Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Hydroquinone Clinical Trials Experience in the drug label.
Postmarketing Experience
Dermatologic: Burning sensation, contact dermatitis, localized erythema
Drug Interactions
There is limited information regarding Hydroquinone Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Hydroquinone in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Hydroquinone in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Hydroquinone during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Hydroquinone in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Hydroquinone in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Hydroquinone in geriatric settings.
Gender
There is no FDA guidance on the use of Hydroquinone with respect to specific gender populations.
Race
There is no FDA guidance on the use of Hydroquinone with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Hydroquinone in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Hydroquinone in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Hydroquinone in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Hydroquinone in patients who are immunocompromised.
Others
Administration and Monitoring
Administration
Topical
- Avoid exposure of treated areas to sunlight.
- Avoid contact with eyes.
Monitoring
- Repigmentation
IV Compatibility
There is limited information regarding the compatibility of Hydroquinone and IV administrations.
Overdosage
There is limited information regarding Hydroquinone overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Hydroquinone Pharmacology in the drug label.
Mechanism of Action
- Hydroquinone inhibits the enzymatic oxidation of tyrosine to 3-(3,4-dihydroxyphenyl) alanine (dopa) and suppresses metabolic processes of melanocytes, thus producing depigmentation of the skin which is reversible
Structure
There is limited information regarding Hydroquinone Structure in the drug label.
Pharmacodynamics
There is limited information regarding Hydroquinone Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Hydroquinone Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Hydroquinone Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Hydroquinone Clinical Studies in the drug label.
How Supplied
There is limited information regarding Hydroquinone How Supplied in the drug label.
Storage
- Store at room temperature (15-30°C / 59-86°F).
- Close cap securely after each use.
Images
Drug Images
{{#ask: Page Name::Hydroquinone |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Hydroquinone |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
(Patient Counseling Information)
Precautions with Alcohol
Alcohol-Hydroquinone interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
ACTIVE 4
Look-Alike Drug Names
There is limited information regarding Hydroquinone Look-Alike Drug Names in the drug label.
Drug Shortage Status
Drug Shortage
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
{{#subobject:
|Label Page=Hydroquinone |Label Name=Hydroquinone ingredients and appearance.png
}}
{{#subobject:
|Label Page=Hydroquinone |Label Name=Active 4.jpg
}}